title: Fungal nail infections (onychomycosis): a never-ending story?
authors.affiliation: Center for Medical Mycology, University Hospitals of Cleveland, Cleveland, Ohio, United States of America.
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Ghannoum
authors.affiliation: Center for Medical Mycology, University Hospitals of Cleveland, Cleveland, Ohio, United States of America.
authors.forename: Nancy
authors.initials: N
authors.lastname: Isham
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D000367:Age Factors; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004197:Disease Reservoirs / Q000382:microbiology; D004334:Drug Administration Schedule; D004821:Epidermophyton / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology; D005533:Foot Dermatoses / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D006229:Hand Dermatoses / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D008864:Microsporum / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology; D014009:Onychomycosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D015995:Prevalence; D012008:Recurrence; D012307:Risk Factors; D013172:Spores, Fungal / Q000187:drug effects / Q000254:growth & development / Q000502:physiology; D014249:Trichophyton / Q000187:drug effects* / Q000254:growth & development / Q000502:physiology
chemical_list: D000935:Antifungal Agents